@inproceedings{794018cb5d9d4a628736a33b6aaed825,
title = "Role of statins in cerebral vasospasm",
abstract = "3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, commonly known as statins, are widely used clinically for their lipid lowering properties. Recent evidence shows that statins are also effective in ameliorating cerebral vasospasm, which occurs as sequelae of subarachnoid haemorrhage. This review focuses on the pleiotropic effects of statins, and the putative mechanisms involved in statin mediated attenuation of cerebral vasospasm. {\textcopyright} 2008 Springer-Verlag.",
keywords = "Akt, Cerebral vasospasm, Rho, eNOS, pleiotropic effects, statin, subarachnoid haemorrhage, Nitric Oxide Synthase Type III/genetics, Vasospasm, Intracranial/drug therapy, Animals, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Muscle, Smooth, Vascular/enzymology, Disease Models, Animal, Subarachnoid Hemorrhage/drug therapy",
author = "T. Sugawara and R. Ayer and Zhang, \{John H.\}",
note = "3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, commonly known as statins, are widely used clinically for their lipid lowering properties. Recent evidence shows that statins are",
year = "2008",
month = mar,
day = "25",
doi = "10.1007/978-3-211-75718-5\_59",
language = "English",
isbn = "9783211757178",
series = "Acta Neurochirurgica, Supplementum",
publisher = "Springer Vienna",
number = "104",
pages = "287--290",
booktitle = "Cerebral Vasospasm",
edition = "104",
}